Enter the first few characters of Company and click 'Go'
Nine Month Financial Results of Marksans Pharma Ltd.(Figures in Rs crores)
|
|
Dec 31, 2023 |
Dec 31, 2022 |
Dec 31, 2021 |
Dec 31, 2020 |
Dec 31, 2019 |
Other Income |
49.88 |
56.18 |
34.60 |
19.25 |
0.26 |
Raw Material |
302.79 |
253.13 |
244.01 |
214.54 |
151.79 |
Power And Fuel |
0 |
0 |
0 |
0 |
0 |
Employee Expenses |
55.63 |
40.67 |
45.45 |
38.97 |
36.16 |
Excise |
|
|
|
|
|
Admin And Selling Expenses |
0 |
0 |
0 |
0 |
0 |
Research And Devlopment Expenses |
0 |
0 |
0 |
0 |
0 |
Expenses Capitalised |
0 |
0 |
0 |
0 |
0 |
Other Expenses |
168.75 |
141.97 |
103.52 |
116.38 |
76.14 |
Provisions Made |
0 |
0 |
0 |
0 |
0 |
Interest |
0.76 |
2.96 |
2.52 |
3.21 |
5.62 |
Gross Profit |
155.15 |
122.42 |
118.93 |
102.97 |
47.74 |
Depreciation |
21.66 |
13.23 |
13.05 |
11.05 |
8.18 |
Taxation |
32.73 |
24.13 |
23.32 |
17.23 |
9.06 |
Extra Ordinary Item |
0 |
0 |
0 |
0 |
0 |
Prior Year Adjustments |
0 |
0 |
0 |
0 |
0 |
Equity Capital |
45.32 |
40.30 |
40.93 |
40.93 |
40.93 |
Equity Dividend Rate |
0 |
0 |
0 |
0 |
0 |
Agg.Of Non-Prom. Shares (in lacs) |
0 |
0 |
0 |
0 |
0 |
Agg.Of Non PromotoHolding (%) |
0 |
0 |
0 |
0 |
0 |
EPS (in Rs.) |
2.22 |
2.11 |
2.02 |
1.82 |
0.74 |
|
Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article